Paper · 11274381
Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes.
Yu K and 1 other. Proc Natl Acad Sci U S A, 2001. Cited by 43 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes. Papers, record 11274381. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11274381
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acrocephalosyndactylia | Major topic |
| Receptor Protein-Tyrosine Kinases | Major topic |
| Receptors, Fibroblast Growth Factor | Major topic |
| Animals | |
| Disease Models, Animal | |
| Fibroblast Growth Factors | |
| Humans | |
| Ligands | |
| Mice | |
| Mutation | |
| Phenotype | |
| Receptor, Fibroblast Growth Factor, Type 2 | |
| Signal Transduction |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| HD30652 | NICHD NIH HHS | United States | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 11,274,405 | A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes. | https://conductscience.org/library/papers/11274405 |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,631,169 | An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. | Development | 2000 | https://conductscience.org/library/papers/10631169 | PubMed |
| 2 | 7,719,344 | Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. | Nat Genet | 1995 | https://conductscience.org/library/papers/7719344 | PubMed |
| 3 | 7,583,099 | Functions of fibroblast growth factors and their receptors. | Curr Biol | 1995 | https://conductscience.org/library/papers/7583099 | PubMed |
| 4 | 8,585,128 | Fibroblast-growth-factor receptor mutations in human skeletal disorders. | Trends Genet | 1995 | https://conductscience.org/library/papers/8585128 | PubMed |
| 5 | 8,663,044 | Receptor specificity of the fibroblast growth factor family. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8663044 | PubMed |
| 6 | 8,755,573 | Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8755573 | PubMed |
| 7 | 9,427,842 | The heparan sulfate-fibroblast growth factor family: diversity of structure and function. | Prog Nucleic Acid Res Mol Biol | 1998 | https://conductscience.org/library/papers/9427842 | PubMed |
| 8 | 9,435,295 | Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. | Development | 1998 | https://conductscience.org/library/papers/9435295 | PubMed |
| 9 | 9,560,232 | Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9560232 | PubMed |
| 10 | 9,582,367 | Characterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarities with keratinocyte growth factor (FGF-7). | J Biol Chem | 1998 | https://conductscience.org/library/papers/9582367 | PubMed |
1 to 10 of 33
See all 33 referencesCited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,806,206 | Mendelian inheritance revisited: dominance and recessiveness in medical genetics. | Nat Rev Genet | 2023 | https://conductscience.org/library/papers/36806206 | PubMed |
| 34,007,277 | 2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology. | J Oncol | 2021 | https://conductscience.org/library/papers/34007277 | PubMed |
| 30,234,486 | Quantification of gene expression patterns to reveal the origins of abnormal morphogenesis. | Elife | 2018 | https://conductscience.org/library/papers/30234486 | PubMed |
| 27,859,991 | Signaling networks in joint development. | Dev Dyn | 2017 | https://conductscience.org/library/papers/27859991 | PubMed |
| 26,589,935 | From Bench to Bedside and Back: Improving Diagnosis and Treatment of Craniofacial Malformations Utilizing Animal Models. | Curr Top Dev Biol | 2015 | https://conductscience.org/library/papers/26589935 | PubMed |
| 26,340,332 | A Genetic-Pathophysiological Framework for Craniosynostosis. | Am J Hum Genet | 2015 | https://conductscience.org/library/papers/26340332 | PubMed |
| 26,220,993 | Fibroblast growth factor signaling in skeletal development and disease. | Genes Dev | 2015 | https://conductscience.org/library/papers/26220993 | PubMed |
| 25,772,309 | The Fibroblast Growth Factor signaling pathway. | Wiley Interdiscip Rev Dev Biol | 2015 | https://conductscience.org/library/papers/25772309 | PubMed |
| 24,489,893 | A Ser252Trp mutation in fibroblast growth factor receptor 2 (FGFR2) mimicking human Apert syndrome reveals an essential role for FGF signaling in the regulation of endochondral bone formation. | PLoS One | 2014 | https://conductscience.org/library/papers/24489893 | PubMed |
| 23,732,477 | Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology. | Cold Spring Harb Perspect Biol | 2013 | https://conductscience.org/library/papers/23732477 | PubMed |
1 to 10 of 19
See all 19 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FGFR2 | 2,263 | PubTator's text mining | https://conductscience.org/library/genes/2263 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11274381
GET https://conductscience.org/api/papers/v1/11274381/references?page=2